A mobile app to help underserved adults with asthma manage their condition.
Official title: A novel patient-facing mobile platform to collect and implement patient-reported outcomes and voice biomarkers in underserved adult patients with asthma
Funded at Albert Einstein College of Medicine · NIH-11257432 · Data updated 2026-11-12
This study is creating a helpful mobile app for adults with asthma, especially those who may not have easy access to care, to help them manage their condition better by using their voice to check their breathing and offering personalized tips and support.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $271,283 |
| NIH project number | 4R33HS028892-03 |
| Project ID | NIH-11257432 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are underserved adult patients with asthma who may struggle with medication adherence and self-management.
✕Less likely to help
Patients without asthma or those who do not have access to mobile technology may not benefit from this research.
What this research studies
This research focuses on developing a user-friendly mobile platform designed to assist underserved adult patients with asthma in managing their health. The platform will utilize vocal biomarker technology to assess respiratory function through voice samples, allowing for personalized feedback and support. It aims to enhance patient engagement by collecting patient-reported outcomes (PROs) and providing educational resources, goal-setting tools, and decision-making support. By addressing social determinants of health and improving self-management skills, this initiative seeks to improve asthma care for minority populations.
Why it matters
Potential benefit: If successful, this research could significantly improve asthma management and health outcomes for underserved patients.
How similar studies have gone: Previous studies have shown promise in using mobile platforms and vocal biomarker technology for respiratory conditions, indicating potential success for this approach.
Where this research is happening
-
Albert Einstein College of Medicine
Bronx, United States Active
Researchers
- Principal investigator: Feldman, Jonathan M. — Albert Einstein College of Medicine
- Study coordinator: Feldman, Jonathan M.
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.